Henry Schein Inc

Healthcare · Medical Distribution

84.80$ +0.7% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

Henry Schein Inc (HSIC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 3,458 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HSIC
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	2,865	3,121	2,923	3,059	3,161	3,318	3,220	3,327	3,280	3,375	2,360	2,448	2,509	2,669	2,429	1,684	2,840	3,166	2,925	2,967	3,178	3,331	3,179	3,030	3,067	3,371	3,060	3,100	3,162	3,017	3,172	3,136	3,174	3,191	3,168	3,240	3,339	3,437	3,368	3,458	13,602
Cost of Revenue	2,076	2,259	2,100	2,220	2,325	2,417	1,554	1,598	1,633	1,722	1,609	1,680	1,748	1,858	1,683	1,230	2,086	2,306	2,034	2,077	2,266	2,351	2,253	2,130	2,198	2,417	2,138	2,174	2,226	2,150	2,221	2,181	2,245	2,261	2,230	2,288	2,381	2,443	2,298	2,357	9,479
Gross Profit	789	862	823	839	836	901	719	718	722	751	752	767	761	811	746	454	754	860	891	890	912	980	926	900	869	954	922	926	936	867	951	955	929	930	938	952	958	994	1,070	1,101	4,123
Research & Development	0.0	0.0	–	–	0.0	0.0	–	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	599	548	629	629	629	566	660	686	673	604	575	593	575	542	567	446	560	595	658	679	701	774	682	680	648	761	717	707	725	807	791	781	724	738	738	778	760	808	809	831	3,208
Total Operating Expenses	583	632	629	629	623	660	554	553	552	558	575	593	575	615	567	446	560	674	658	679	701	776	682	680	648	761	717	707	725	807	791	781	724	738	736	777	752	808	888	901	3,349
Operating Income	206	230	194	211	214	241	165	166	170	193	177	174	186	195	179	8.5	195	186	233	211	211	203	244	220	221	193	205	219	211	60	160	174	205	192	202	175	206	186	182	200	774
Interest Expense	7.5	9.9	11	12	13	17	17	17	20	21	16	13	12	9.3	7.8	10	11	12	6.5	6.4	6.6	8.2	7.0	9.0	11	17	14	19	25	29	30	32	34	35	35	38	38	39	39	43	159
Pre-Tax Income	196	207	187	208	210	215	151	148	113	146	163	157	185	193	172	-15	181	174	232	212	211	196	243	219	208	66	167	189	182	18	130	138	131	127	148	125	137	135	150	136	558
Income Tax Expense	57	59	39	58	59	206	36	34	17	21	39	36	42	42	38	-1.0	29	29	57	48	49	43	57	52	46	15	39	41	39	1.0	32	33	32	31	35	31	28	32	38	34	132
Net Income	134	139	141	136	138	-8.5	140	141	121	133	110	115	141	143	130	-11	142	141	166	156	155	147	181	160	150	47	121	140	137	18	93	104	99	94	110	86	101	101	107	94	403
EBITDA	246	261	243	263	267	296	201	196	162	198	217	214	238	248	226	41	233	229	282	262	264	260	301	276	268	132	229	264	273	111	230	238	236	237	253	235	255	256	256	264	1,031

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings